Rheumatoid Arthritis
📧 Sign up to get email alerts when something new happens for Rheumatoid Arthritis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2007-12-07Clinical Trial Update: Phase 2 Clinical Study in Rheumatoid Arthritis With an Investigational Oral p38 MAP Kinase Inhibitor VX-702 [Phase 2]
The document reports the completion of a Phase 2 clinical trial evaluating the investigational p38 MAP kinase inhibitor VX-702 for rheumatoi…
-
CLINICAL_TRIALS trial_result · 2007-12-07Clinical Trial Update: A Study in Rheumatoid Arthritis With an Investigational Oral p38 MAP Kinase Inhibitor VX-702 [Phase 2]
This document reports the completion of a Phase 2 clinical trial evaluating VX-702, an investigational p38 MAP kinase inhibitor, in patients…
-
CLINICAL_TRIALS trial_result · 2007-12-05Clinical Trial Update: Leflunomide + Methotrexate in Rheumatoid Arthritis [Phase 4]
This document reports a Phase 4 clinical trial update evaluating the combination of Leflunomide and Methotrexate in rheumatoid arthritis. Th…
-
CLINICAL_TRIALS trial_result · 2007-12-05Clinical Trial Update: A Study Evaluating 10 mg and 25 mg Doses of Etanercept in Patients With Rheumatoid Arthritis [Phase 3]
A Phase 3 study evaluating 10 mg and 25 mg doses of etanercept for rheumatoid arthritis has completed.
-
CLINICAL_TRIALS trial_result · 2007-11-27Clinical Trial Update: Effects of MEDI-522 On Disease Activity and Progression of Joint Damage in Patients With Active Rheumatoid Arthritis Suboptimally Responding to Methotrexate [Phase 2]
Phase 2 trial of MEDI-522 in active rheumatoid arthritis patients suboptimally responding to methotrexate reports on disease activity and pr…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2007-11-20FDA Approved: MELOXICAM — Supplemental Application (Zydus Pharmaceuticals USA Inc.)
FDA approved a supplemental application for Meloxicam filed by Zydus Pharmaceuticals USA Inc.
-
FDA approval · 2007-11-07FDA Approved: NAPROXEN — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for Naproxen (generic Naproxen) from Hikma Pharmaceuticals USA Inc., resulting in approval of a gene…
-
CLINICAL_TRIALS trial_result · 2007-10-29Clinical Trial Update: Medical In-Patient Rehabilitation in Rheumatoid Arthritis [Phase 3]
A Phase 3 clinical trial investigating medical in-patient rehabilitation for rheumatoid arthritis has completed (status: COMPLETED). No resu…
-
FDA approval · 2007-10-25FDA Approved: MELOXICAM — Supplemental Application (AiPing Pharmaceutical, Inc)
FDA approved a supplemental application for MELOXICAM from AiPing Pharmaceutical, Inc., resulting in the availability of a generic meloxicam…
-
CLINICAL_TRIALS trial_result · 2007-10-19Clinical Trial Update: Study Evaluating the Efficacy and Safety of Etanercept [Phase 4]
A Phase 4 clinical trial evaluating the efficacy and safety of etanercept for rheumatoid arthritis has been completed.
-
CLINICAL_TRIALS trial_result · 2007-10-19Clinical Trial Update: A Comparison of Methotrexate Alone or Combined to Infliximab or to Pulse Methylprednisolone in Early Rheumatoid Arthritis: A Magnetic Resonance Imaging Study [Phase 4]
A Phase 4 MRI study in early rheumatoid arthritis compares methotrexate alone, methotrexate with infliximab, and methotrexate with pulse met…
-
FDA approval · 2007-10-16FDA Approved: MELOXICAM — Supplemental Application (Terrain Pharmaceuticals, Inc.)
The FDA approved a supplemental application for meloxicam from Terrain Pharmaceuticals, Inc., confirming continued approval for its approved…
-
CLINICAL_TRIALS trial_result · 2007-10-03Clinical Trial Update: Quality of Life Study With Adalimumab in Rheumatoid Arthritis [Phase 3]
This document reports a completed Phase 3 trial evaluating the quality of life effects of adalimumab in rheumatoid arthritis.
-
FDA approval · 2007-09-25FDA Approved: NAPROXEN — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for Naproxen from Hikma Pharmaceuticals USA Inc., indicating an approved change or addition to the N…
-
FDA approval · 2007-09-21FDA Approved: HYDROXYCHLOROQUINE SULFATE — Original Application (Zydus Lifesciences Limited)
FDA approves the original ANDA for hydroxychloroquine sulfate, a generic version manufactured by Zydus Lifesciences Limited.
-
CLINICAL_TRIALS research · 2007-08-31Clinical Trial Update: Remission Induction in Very Early Rheumatoid Arthritis [Phase 4]
This item provides an update on a Phase 4 trial evaluating remission induction in very early rheumatoid arthritis.
-
CLINICAL_TRIALS trial_result · 2007-08-29Clinical Trial Update: Adalimumab in Combination With Methotrexate vs Methotrexate Alone in Early Rheumatoid Arthritis [Phase 3]
Phase 3 trial evaluating adalimumab in combination with methotrexate versus methotrexate alone in early rheumatoid arthritis has completed.
-
CLINICAL_TRIALS trial_result · 2007-08-29Clinical Trial Update: Efficacy of HUMIRA in Subjects With Active Rheumatoid Arthritis [Phase 4]
Phase 4 trial update discussing the efficacy of HUMIRA in subjects with active rheumatoid arthritis.
-
CLINICAL_TRIALS trial_result · 2007-08-29Clinical Trial Update: Adalimumab Administered in Korean Rheumatoid Arthritis Subjects Treated With Methotrexate [Phase 3]
A Phase 3 clinical trial evaluating adalimumab in Korean rheumatoid arthritis patients treated with methotrexate has completed.
-
CLINICAL_TRIALS trial_result · 2007-08-29Clinical Trial Update: Tai Chi for Patients With Rheumatoid Arthritis [NA]
The document reports the completion of a trial evaluating Tai Chi for patients with rheumatoid arthritis.
-
FDA approval · 2007-08-24FDA Approved: DICLOFENAC SODIUM AND MISOPROSTOL — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for the Diclofenac sodium and misoprostol combination product from Mylan Pharmaceuticals.
-
FDA approval · 2007-08-01FDA Approved: NEORAL — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application for NEORAL (cyclosporine) submitted by Novartis Pharmaceuticals Corporation.
-
CLINICAL_TRIALS trial_result · 2007-07-31Clinical Trial Update: dnaJ Peptide for Relieving Rheumatoid Arthritis [Phase 2]
Phase 2 clinical trial evaluating the dnaJ Peptide for relief of symptoms in Rheumatoid Arthritis has completed (status: COMPLETED).
-
FDA approval · 2007-07-30FDA Approved: HUMIRA — Supplemental Application (Cordavis Limited)
The FDA approved a supplemental application for Humira (adalimumab) submitted by Cordavis Limited.
-
FDA approval · 2007-07-26FDA Approved: NAPROXEN SODIUM — Original Application (Dr. Reddy's Laboratories Inc.)
FDA approves Dr. Reddy's Laboratories' naproxen sodium as a generic version via an Original Abbreviated New Drug Application (ANDA). This co…